T-cell Activation Leads to Poor Activation of the HIV-1 Clade E Long Terminal Repeat and Weak Association of Nuclear Factor-κB and NFAT with Its Enhancer Region

The enhancer region in the human immunodeficiency virus type 1 (HIV-1) 5′-long terminal repeat (LTR) is very important for viral transcription. This promoter sequence binds both nuclear factor-κB and NFAT, two important modulators of HIV-1 gene expression. Previous studies have indicated that the en...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2004-12, Vol.279 (51), p.52949-52960
Hauptverfasser: Lemieux, Anne-Marie, Paré, Marie-Ève, Audet, Brigitte, Legault, Éric, Lefort, Sylvain, Boucher, Nancy, Landry, Sébastien, van Opijnen, Tim, Berkhout, Ben, Naghavi, Mojgan H., Tremblay, Michel J., Barbeau, Benoit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The enhancer region in the human immunodeficiency virus type 1 (HIV-1) 5′-long terminal repeat (LTR) is very important for viral transcription. This promoter sequence binds both nuclear factor-κB and NFAT, two important modulators of HIV-1 gene expression. Previous studies have indicated that the enhancer regions of the different HIV-1 clade LTRs differ in their number of NF-κB-binding sites. In this study, we have compared the activation potential of the different HIV-1 clade and HIV-2 LTRs and assessed their interaction with NFAT and NF-κB. In T-cell lines and primary CD4+ T-cells, the results showed that the HIV-1 clade E LTR (with a single NF-κB-binding site) was the weakest LTR regardless of the tested activators, whereas the HIV-2 LTR was the most responsive LTR. The clade E enhancer region was also demonstrated to be the weakest enhancer region in transfection experiments with luciferase reporter-based vectors. Electrophoretic mobility shift assays with extracts from activated CD4+ T-cells indicated that, although NF-κB and NFAT bound all enhancers, HIV-1 clade E and HIV-2 LTR enhancers were poor binding targets for these two factors. Weak NFAT binding to clade E enhancers was also confirmed using NFAT1-expressing 293T cells in competition experiments. We have also shown the absence of interaction of NF-κB or NFAT with the third NF-κB repeat present in clade C. However, the clade C enhancer bound NFAT more efficiently than all other enhancer regions tested. Our results hence demonstrate for the first time that differences in the binding of NF-κB and NFAT to the enhancer regions could be responsible for some of the observed variation in HIV-1 clade LTR activation, whereas HIV-2 LTR activation seems mostly independent of these interactions.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M409896200